Cancer BiologybioRxivPreprint
Combination fedratinib and venetoclax has activity against human B-ALL with high FLT3 expression
S. P. Rinella, Haley C Bell, Nicholas J Hess…·Christian M. Capitini
This study shows that combining fedratinib and venetoclax effectively kills B-ALL cells with high FLT3 expression, both in vitro and in vivo.
3 citations